Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AMERICAN PHARMACEUTICAL INSTITUTE

Executive Summary

AMERICAN PHARMACEUTICAL INSTITUTE Director Robert Helms has resigned after a year-and-a-half as head of the APhA-affiliated think tank. The American Pharmaceutical Association does not have an official comment on Helms' departure or a possible replacement. However, the institute is understood to be experiencing funding difficulties. Helms was recruited to the institute in April 1989 after a number of years in HHS management positions with the Reagan Administration, culminating as Assistant Secretary for Planning and Administration. The institute was established by the pharmacy organization during Jack Schlegel's tenure at APhA as a policy group that would examine changes in the delivery and financing of health care. APhA initially identified the establishment of the think tank as a long-term objective. Association officers have said in the past that it would take four to seven years for the institute to get established and have an impact on pharmacy. However, the association may have cooled a bit toward the project.
UsernamePublicRestriction

Register

PS017991

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel